Products for Research Use Only
RegisterLogin

DOTA-Lanreotide

CAT: 0804-HY-P10730Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10730Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DOTA-Lanreotide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].
CAS Number
213187-44-1
UNSPSC
12352005
Target
Radionuclide-Drug Conjugates (RDCs)
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dota-lanreotide.html
Smiles
O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)C(N[C@H](C(N)=O)[C@H](O)C)=O)NC([C@H](NC(CN2CCN(CCN(CCN(CC2)CC(O)=O)CC(O)=O)CC(O)=O)=O)CC3=CC4=C(C=CC=C4)C=C3)=O)=O)CC5=CC=C(C=C5)O)N[C@@H]1CC6=CNC7=CC=CC=C67
Molecular Formula
C70H95N15O17S2
Molecular Weight
1482.72
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P1959-01Lanreotide
HY-P1959A-01Lanreotide (acetate)
HY-P1959BLanreotide (diTFA)
HY-163040DOTA-Tyr-Lys-DOTA
HY-P11254DOTA-FAPT
HY-163039DOTA-biotin
HY-139564DOTA Zoledronate
HY-W802013DOTA-4AMP
HY-W038001DOTA-benzene
HY-P5128-01DOTA-JR11

Alternative Products

CatalogName
PT_41366-01Lanreotide (Lanreotide)
4067760.0001Lanreotide
CFA98474-01Lanreotide acetate

Popular Products